Related Experiment Videos
Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus
V Lilleby1, M Haugen, L Mørkrid
1Department of Rheumatology, Rikshospitalet University Hospital, NO-0027 Oslo, Norway. vibke.lilleby@rikshospitalet.no
Insights
Childhood-onset systemic lupus erythematosus (SLE) patients have higher body fat and lower lean mass than healthy individuals. Corticosteroid use is a key factor, contributing to an increased risk of heart disease.
Area of Science:
- Rheumatology
- Pediatrics
- Endocrinology
Background:
- Systemic lupus erythematosus (SLE) is associated with systemic inflammation, corticosteroid therapy, and reduced physical activity, all potential contributors to altered body composition.
- Understanding body composition changes in childhood-onset SLE is crucial for managing long-term health outcomes.
Purpose of the Study:
- To compare body composition between childhood-onset SLE patients and healthy controls.
- To investigate the impact of disease characteristics, corticosteroid use, and lifestyle factors on body fat mass, serum lipids, and lipoproteins in pediatric SLE.
Main Methods:
- A cross-sectional study involving 68 childhood-onset SLE patients and 68 matched healthy controls.
- Dual-energy X-ray absorptiometry (DXA) was used to measure fat mass and lean tissue mass.
- Multiple linear regression analysis assessed the influence of disease factors, glucocorticosteroids, disease activity, physical activity, and diet on fat mass. Serum lipid and lipoprotein levels were also measured.
Main Results:
- SLE patients exhibited significantly higher fat mass (35.3% vs. 30.9%) and lower lean mass (39.7 kg vs. 44.4 kg) compared to controls.
- Corticosteroid use and SLE itself were independent predictors of increased fat mass; disease activity, physical activity, and diet had minimal impact.
- Patients displayed lower high-density lipoprotein (HDL) cholesterol and apolipoprotein A1 (apo A1) levels, and a higher apo B/apo A1 ratio, indicating a more proatherogenic lipid profile.
Conclusions:
- Childhood-onset SLE is characterized by unfavorable body composition, with increased fat mass and decreased lean mass compared to healthy peers.
- Corticosteroid therapy is a significant independent predictor of increased fat mass in these patients.
- The observed proatherogenic lipid profile in SLE patients elevates their risk for coronary heart disease.
Objectives:
Systemic inflammation, corticosteroid therapy, and reduced physical activity are risk factors for altered body composition in patients with systemic lupus erythematosus (SLE). The aim of this study was to assess whether body composition differs between childhood-onset SLE patients and healthy controls, and to investigate the impact of disease characteristics and lifestyle factors on body fat mass, serum lipids, and lipoproteins.
Methods:
Fat mass and lean tissue mass were measured in a cross-sectional study of 68 childhood-onset SLE patients and 68 matched healthy controls by dual-energy X-ray absorptiometry (DXA). The influence of disease, glucocorticosteroids, disease activity and severity, physical activity, and dietary intake on fat mass was evaluated by multiple linear regression analysis. Serum lipid and lipoprotein levels were measured.
Results:
Patients had a significantly higher fat mass [mean (SD) 35.3 (10.8) vs. 30.9 (11.1)%; p = 0.024] and lower lean mass [39.7 (9.8) vs. 44.4 (1.5) kg; p = 0.003] than controls. Corticosteroid use and the disease itself were significant independent predictors of greater fat mass, while disease activity, physical activity, and dietary intake had only a minor influence. Mean high density lipoprotein (HDL) cholesterol and apolipoprotein A1 (apo A1) levels were significantly lower (p<0.001), and the mean apo B/apo A1 ratio significantly higher (p = 0.004), in patients than in controls.
Conclusion:
Childhood-onset SLE patients had a higher fat mass and lower lean mass than healthy controls and corticosteroid use was an independent predictor of increased fat mass. Patients had a more proatherogenic lipid profile, which will contribute to the increased risk of coronary heart disease in SLE patients.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Cholesterol: Significance and Regulation
Considering cholesterol and...